Grant of Interim Extension of the Term of U.S. Patent No. 7,534,790; Vernakalant Hydrochloride, 10251 [2021-03427]

Download as PDF Federal Register / Vol. 86, No. 32 / Friday, February 19, 2021 / Notices Act. The marking of fishing gear is also valuable in actions concerning damage, loss, and civil proceedings. The requirements imposed in the U.S. southeast region are for aquacultured live rock; golden crab traps; spiny lobster traps; black sea bass pots; Spanish mackerel gillnets; and buoy gear. should be aware that your entire comment, including your personal identifying information, may be made publicly available at any time. While you may ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. II. Method of Collection Sheleen Dumas, Department PRA Clearance Officer, Office of the Chief Information Officer, Commerce Department. Markings, such as numbers, are placed directly on fishing vessels and gear. [FR Doc. 2021–03366 Filed 2–18–21; 8:45 am] III. Data BILLING CODE 3510–22–P OMB Control Number: 0648–0358. Form Number(s): None. Type of Review: Regular submission (extension of a current information collection). Affected Public: Business or other forprofit organizations. Estimated Number of Respondents: 7,825. Estimated Time per Response: Vessel marking: 75 minutes. Gear marking: Aquacultured live rocks, 10 seconds each; golden crab traps, 2 minutes each; spiny lobster traps, 7 minutes each; sea bass pots, 16 minutes each; and Spanish mackerel gillnets, 20 minutes each; and buoy gear, 10 minutes each. Estimated Total Annual Burden Hours: 51,070. Estimated Total Annual Cost to Public: $673,277 in recordkeeping and reporting costs. Respondent’s Obligation: Mandatory. Legal Authority: Magnuson-Stevens Act, 16 U.S.C. 1801 et seq. tkelley on DSKBCP9HB2PROD with NOTICES IV. Request for Comments We are soliciting public comments to: (a) Evaluate whether the proposed information collection is necessary for the proper functions of the Department, including whether the information will have practical utility; (b) Evaluate the accuracy of our estimate of the time and cost burden for this proposed collection, including the validity of the methodology and assumptions used; (c) Evaluate ways to enhance the quality, utility, and clarity of the information to be collected; and (d) Minimize the reporting burden on those who are to respond, including the use of automated collection techniques or other forms of information technology. Comments that you submit in response to this notice are a matter of public record. We will include or summarize each comment in our request to OMB to approve this information collection request. Before including your address, phone number, email address, or other personal identifying information in your comment, you VerDate Sep<11>2014 21:07 Feb 18, 2021 Jkt 253001 DEPARTMENT OF COMMERCE Patent and Trademark Office [Docket No.: PTO–P–2021–0009] Grant of Interim Extension of the Term of U.S. Patent No. 7,534,790; Vernakalant Hydrochloride United States Patent and Trademark Office, Commerce. ACTION: Notice of interim patent term extension. AGENCY: The United States Patent and Trademark Office has issued an order granting interim extension for a oneyear interim extension of the term of U.S. Patent No. 7,534,790. FOR FURTHER INFORMATION CONTACT: Raul Tamayo by telephone at 571–272–7728; by mail marked to his attention and addressed to the Commissioner for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, Alexandria, VA 22313– 1450; by fax marked to his attention at 571–273–7728; or by email to raul.tamayo@uspto.gov. SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code, generally provides that the term of a patent may be extended for a period of up to five years if the patent claims a product, or a method of making or using a product, that has been subject to certain defined regulatory review, and that the patent may be extended for interim periods of up to one year if the regulatory review is anticipated to extend beyond the expiration date of the patent. On February 9, 2021, Correvio International Sa`rl, the patent owner of record, timely filed an application under 35 U.S.C. 156(d)(5) for a third interim extension of the term of U.S. Patent No. 7,534,790. The patent claims the human drug product vernakalant hydrochloride. The application for patent term extension indicates that New Drug Application (NDA) 22–034 was submitted to the Food and Drug SUMMARY: PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 10251 Administration (FDA) on December 19, 2006. Review of the patent term extension application indicates that, except for permission to market or use the product commercially, the subject patent would be eligible for an extension of the patent term under 35 U.S.C. 156, and that the patent should be extended for one year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory review period will continue beyond the twiceextended expiration date of the patent, March 31, 2021, interim extension of the patent term under 35 U.S.C. 156(d)(5) is appropriate. An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. Patent No. 7,534,790 is granted for a period of one year from the extended expiration date of the patent. Robert Bahr, Deputy Commissioner for Patent Examination Policy, United States Patent and Trademark Office. [FR Doc. 2021–03427 Filed 2–18–21; 8:45 am] BILLING CODE 3510–16–P COMMODITY FUTURES TRADING COMMISSION Global Markets Advisory Committee Commodity Futures Trading Commission. ACTION: Notice of meeting. AGENCY: The Commodity Futures Trading Commission (CFTC) announces that on March 11, 2021, from 9:00 a.m. to 1:00 p.m. (Eastern Standard Time), the Global Markets Advisory Committee (GMAC) will hold a public meeting via teleconference. At this meeting, the GMAC will continue discussions on the impact of market volatility related to the coronavirus pandemic and recent effects on international central counterparties and the global clearing ecosystem; and hear presentations and provide dialogue on matters related to retail participation in the derivatives markets. DATES: The meeting will be held on March 11, 2021, from 9:00 a.m. to 1:00 p.m. (Eastern Standard Time). Members of the public who wish to submit written statements in connection with the meeting should submit them by March 18, 2021. ADDRESSES: The meeting will take place via teleconference. You may submit public comments, identified by ‘‘Global Markets Advisory Committee,’’ via the CFTC’s website, http:// comments.cftc.gov. If you are unable to submit comments via the CFTC’s website, contact Andre´e Goldsmith, SUMMARY: E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 86, Number 32 (Friday, February 19, 2021)]
[Notices]
[Page 10251]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03427]


-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Patent and Trademark Office

[Docket No.: PTO-P-2021-0009]


Grant of Interim Extension of the Term of U.S. Patent No. 
7,534,790; Vernakalant Hydrochloride

AGENCY: United States Patent and Trademark Office, Commerce.

ACTION: Notice of interim patent term extension.

-----------------------------------------------------------------------

SUMMARY: The United States Patent and Trademark Office has issued an 
order granting interim extension for a one-year interim extension of 
the term of U.S. Patent No. 7,534,790.

FOR FURTHER INFORMATION CONTACT: Raul Tamayo by telephone at 571-272-
7728; by mail marked to his attention and addressed to the Commissioner 
for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, Alexandria, VA 
22313-1450; by fax marked to his attention at 571-273-7728; or by email 
to [email protected].

SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code, 
generally provides that the term of a patent may be extended for a 
period of up to five years if the patent claims a product, or a method 
of making or using a product, that has been subject to certain defined 
regulatory review, and that the patent may be extended for interim 
periods of up to one year if the regulatory review is anticipated to 
extend beyond the expiration date of the patent. On February 9, 2021, 
Correvio International S[agrave]rl, the patent owner of record, timely 
filed an application under 35 U.S.C. 156(d)(5) for a third interim 
extension of the term of U.S. Patent No. 7,534,790. The patent claims 
the human drug product vernakalant hydrochloride. The application for 
patent term extension indicates that New Drug Application (NDA) 22-034 
was submitted to the Food and Drug Administration (FDA) on December 19, 
2006.
    Review of the patent term extension application indicates that, 
except for permission to market or use the product commercially, the 
subject patent would be eligible for an extension of the patent term 
under 35 U.S.C. 156, and that the patent should be extended for one 
year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory 
review period will continue beyond the twice-extended expiration date 
of the patent, March 31, 2021, interim extension of the patent term 
under 35 U.S.C. 156(d)(5) is appropriate.
    An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S. 
Patent No. 7,534,790 is granted for a period of one year from the 
extended expiration date of the patent.

Robert Bahr,
Deputy Commissioner for Patent Examination Policy, United States Patent 
and Trademark Office.
[FR Doc. 2021-03427 Filed 2-18-21; 8:45 am]
BILLING CODE 3510-16-P